Economic evaluation of outpatients with type 2 diabetes mellitus assisted by a pharmaceutical care service

objective: to analyze the costs related to visits and drug prescription in outpatients with type 2 diabetes mellitus assisted by a pharmaceutical care service. subjects and methods: a prospective and experimental study was carried out. seventy one patients were divided into two groups: control and pharmaceutical care. patients in the pharmaceutical care group were followed up monthly by a single clinical pharmacist. results: the pharmaceutical care group had a statistically significant reduction in costs of metformin and emergency department visits, and increased costs with their family physicians. on the other hand, the control group had a statistically significant increase of 21.3% in the general costs of treatment and visits. conclusion: the pharmaceutical care group maintained the same costs related to drugs and visits, while the control group showed a significant increase in general costs.